- Home
- MAIA vs PNI Comparison
MAIA vs PNI Comparison
Compare MAIA & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- PNI
- Stock Information
- Founded
- MAIA 2018
- PNI 2002
- Country
- MAIA United States
- PNI United States
- Employees
- MAIA N/A
- PNI N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- PNI Trusts Except Educational Religious and Charitable
- Sector
- MAIA Health Care
- PNI Finance
- Exchange
- MAIA Nasdaq
- PNI Nasdaq
- Market Cap
- MAIA 46.7M
- PNI 75.2M
- IPO Year
- MAIA 2022
- PNI N/A
- Fundamental
- Price
- MAIA $1.78
- PNI $6.69
- Analyst Decision
- MAIA
- PNI
- Analyst Count
- MAIA 0
- PNI 0
- Target Price
- MAIA N/A
- PNI N/A
- AVG Volume (30 Days)
- MAIA 425.1K
- PNI 26.4K
- Earning Date
- MAIA 08-08-2025
- PNI 01-01-0001
- Dividend Yield
- MAIA N/A
- PNI 4.76%
- EPS Growth
- MAIA N/A
- PNI N/A
- EPS
- MAIA N/A
- PNI N/A
- Revenue
- MAIA N/A
- PNI N/A
- Revenue This Year
- MAIA N/A
- PNI N/A
- Revenue Next Year
- MAIA N/A
- PNI N/A
- P/E Ratio
- MAIA N/A
- PNI N/A
- Revenue Growth
- MAIA N/A
- PNI N/A
- 52 Week Low
- MAIA $1.40
- PNI $6.03
- 52 Week High
- MAIA $4.24
- PNI $7.89
- Technical
- Relative Strength Index (RSI)
- MAIA 50.97
- PNI 47.83
- Support Level
- MAIA $1.60
- PNI $6.61
- Resistance Level
- MAIA $1.95
- PNI $6.71
- Average True Range (ATR)
- MAIA 0.10
- PNI 0.07
- MACD
- MAIA 0.00
- PNI 0.01
- Stochastic Oscillator
- MAIA 54.49
- PNI 61.54
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About PNI Pimco New York Municipal Income Fund II of Beneficial Interest
PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.